We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$345M
AUM Growth
+$27.4M
Cap. Flow
+$13.2M
Cap. Flow %
3.83%
Top 10 Hldgs %
54.06%
Holding
32
New
3
Increased
16
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
NOV icon
NOV
NOV
+$15.1M
2
QCOM icon
Qualcomm
QCOM
+$14.8M
3
CI icon
Cigna
CI
+$13M
4
FFIV icon
F5
FFIV
+$4.75M
5
GIS icon
General Mills
GIS
+$2.09M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$10M
2
FLGT icon
Fulgent Genetics
FLGT
+$8.76M
3
AIG icon
American International
AIG
+$7.4M
4
FRSH icon
Freshworks
FRSH
+$6.77M
5
AMD icon
Advanced Micro Devices
AMD
+$4.53M

Sector Composition

Rank Sector Weight
1 Financials 36.75%
2 Healthcare 22.6%
3 Technology 22.13%
4 Energy 12.86%
5 Real Estate 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVN icon
1
Devon Energy
DVN
$51.9B
$29.4M 8.52%
666,841
-65,161
-9% -$2.71M
AIG icon
2
American International
AIG
$41.7B
$21M 6.09%
369,054
-129,930
-26% -$7.4M
CVS icon
3
CVS Health
CVS
$134B
$20.4M 5.91%
197,548
+3,797
+2% +$351K
RNR icon
4
RenaissanceRe
RNR
$13.4B
$19.1M 5.53%
112,679
+4,509
+4% +$706K
QCOM icon
5
Qualcomm
QCOM
$156B
$16.9M 4.89%
+92,178
New +$14.8M
FFIV icon
6
F5
FFIV
$22.9B
$16.6M 4.82%
67,932
+21,412
+46% +$4.75M
C icon
7
Citigroup
C
$224B
$16.5M 4.8%
273,772
-15,135
-5% -$1.01M
CB icon
8
Chubb
CB
$136B
$15.6M 4.52%
80,648
+1,331
+2% +$250K
BMY icon
9
Bristol-Myers Squibb
BMY
$134B
$15.6M 4.52%
249,817
+32,465
+15% +$1.9M
ACGL icon
10
Arch Capital
ACGL
$34.4B
$15.4M 4.46%
345,965
+2,855
+0.8% +$121K
NOV icon
11
NOV
NOV
$6.89B
$15M 4.34%
+1,104,642
New +$15.1M
CI icon
12
Cigna
CI
$74.6B
$14.1M 4.08%
+61,258
New +$13M
AMD icon
13
Advanced Micro Devices
AMD
$793B
$13.3M 3.85%
92,252
-33,675
-27% -$4.53M
DFS
14
DELISTED
Discover Financial Services
DFS
$13.3M 3.84%
114,685
+6,057
+6% +$716K
CYBR
15
DELISTED
CyberArk
CYBR
$13.1M 3.79%
75,324
-7,978
-10% -$1.4M
V icon
16
Visa
V
$684B
$13M 3.76%
59,799
+4,497
+8% +$965K
MA icon
17
Mastercard
MA
$507B
$12.9M 3.75%
36,021
+2,314
+7% +$800K
VMW
18
DELISTED
VMware, Inc
VMW
$9.99M 2.9%
86,254
+7,463
+9% +$981K
HCAT icon
19
Health Catalyst
HCAT
$155M
$9.71M 2.82%
245,186
+30,032
+14% +$1.37M
FLGT icon
20
Fulgent Genetics
FLGT
$481M
$9.44M 2.74%
93,876
-99,707
-52% -$8.76M
PETQ
21
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$8.73M 2.53%
384,280
+68,729
+22% +$1.61M
ROI
22
DELISTED
RiskOn International, Inc. Common Stock
ROI
$6.49M 1.88%
97,007
+1,820
+2% +$193K
GIS icon
23
General Mills
GIS
$19.1B
$5.45M 1.58%
80,891
+32,906
+69% +$2.09M
VZ icon
24
Verizon
VZ
$195B
$3.75M 1.09%
72,086
-30,441
-30% -$1.59M
IRM icon
25
Iron Mountain
IRM
$36.6B
$3.13M 0.91%
59,894
+104
+0.2% +$4.92K
1
2

Similar funds

CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
PC
Permit Capital West Conshohocken, Pennsylvania $294M AUM 27.9% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $294M AUM 26.84% 1-Year Est. Return
BIC
B&I Capital Zurich, Switzerland $294M AUM 3.09% 1-Year Est. Return
TJHA
Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $296M AUM 34.73% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Nepsis Inc's Q4 2021 Portfolio in Review

As of Q4 2021, Nepsis Inc held 32 positions worth $345M, up 8.6% from $317M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Nepsis Inc deployed $13.2M of net new capital in Q4 2021, opening 3 new positions and adding to 16 existing holdings. Its largest new stake was NOV: 1,104,642 shares worth $15M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, down from 40% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Fulgent Genetics, an estimated $8.76M trimmed.

  • Nepsis Inc's largest Q4 2021 buy was NOV: 1,104,642 shares worth $15M.
  • Nepsis Inc added most to F5 in Q4 2021, an estimated $4.75M increase.
  • Nepsis Inc's biggest Q4 2021 reduction was Fulgent Genetics, cutting an estimated $8.76M.
  • Nepsis Inc fully exited Ventas in Q4 2021, selling an estimated $10M.
  • Nepsis Inc's ten largest holdings make up 54% of its $345M portfolio in Q4 2021.
  • Nepsis Inc opened 3 new positions and closed 4 in Q4 2021.
  • Nepsis Inc's portfolio value rose 8.6% quarter-over-quarter to $345M.

Based on Nepsis Inc's 13F filing for Q4 2021, filed 14 Jan 2022.